Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Monica Chowdhury
Observed names:
Chowdhury, Monica,
Monica R. Chowdhury
Institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
Observed institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research,
University of Missouri–Kansas City
ORCID:
0000-0001-7918-5172
Observed ORCID:
0000-0001-7918-5172
OpenAlex ID:
A5042360501
In Vitro Evaluation of a Targeted and Sustained Release System for Retinoblastoma Cells Using Doxorubicin as a Model Drug
2010
·
Sai H.S. Boddu
, Jwala Jwala
, et al.
·
Journal of Ocular Pharmacology and Therapeutics
·
52
BRAF and MEK inhibitors differentially affect nivolumab-induced T cell activation by modulating the TCR and AKT signaling pathways
2018
·
Peng Yue
, Taylor Harper
, et al.
·
OncoImmunology
·
21
PDF
NK cells require immune checkpoint receptor LILRB4/gp49B to control neurotropic Zika virus infections in mice
2022
·
Ha-Na Lee
, Mohanraj Manangeeswaran
, et al.
·
JCI Insight
·
17
PDF
CpG oligodeoxynucleotides and pan-serotype inhibitors control neurotropic dengue infection in novel immune competent neonatal mouse model
2025
·
Mirian Mendoza
, Derek D.C. Ireland
, et al.
·
Emerging Microbes & Infections
·
4
Controlled and Targeted Delivery of Doxorubicin for the Treatment of Retinoblastoma
2010
·
S. H. S. Boddu
, Jeetendra Kumar Gupta
, et al.
·
Investigative Ophthalmology & Visual Science
Show more works
View as search
Works count:
6
Citation count:
94
H-index:
4
I10-index:
3
Year
Topic
Type